-$0.44 Earnings Per Share Expected for Inspire Medical Systems (NYSE:INSP) This Quarter

Equities analysts expect Inspire Medical Systems (NYSE:INSP) to report ($0.44) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Inspire Medical Systems’ earnings. The highest EPS estimate is ($0.37) and the lowest is ($0.55). Inspire Medical Systems reported earnings of ($0.22) per share in the same quarter last year, which indicates a negative year over year growth rate of 100%. The firm is expected to announce its next earnings report on Tuesday, February 25th.

On average, analysts expect that Inspire Medical Systems will report full year earnings of ($1.46) per share for the current financial year, with EPS estimates ranging from ($1.56) to ($1.39). For the next year, analysts expect that the company will report earnings of ($1.54) per share, with EPS estimates ranging from ($1.83) to ($1.04). Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover Inspire Medical Systems.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Tuesday, November 5th. The company reported ($0.34) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.43) by $0.09. The company had revenue of $20.86 million for the quarter, compared to the consensus estimate of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. Inspire Medical Systems’s revenue was up 59.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.22) earnings per share.

A number of equities analysts have weighed in on INSP shares. Berenberg Bank raised shares of Inspire Medical Systems from a “sell” rating to a “hold” rating and increased their price target for the stock from $46.00 to $51.00 in a research note on Wednesday, November 6th. ValuEngine downgraded shares of Inspire Medical Systems from a “hold” rating to a “sell” rating in a research note on Thursday, October 31st. Zacks Investment Research raised shares of Inspire Medical Systems from a “hold” rating to a “strong-buy” rating and set a $69.00 price target on the stock in a research note on Saturday, November 9th. Finally, Dougherty & Co set a $78.00 price target on shares of Inspire Medical Systems and gave the stock a “buy” rating in a research note on Friday, September 27th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Inspire Medical Systems has an average rating of “Hold” and an average target price of $68.25.

NYSE:INSP traded down $0.13 during trading hours on Monday, reaching $70.83. 191,100 shares of the company were exchanged, compared to its average volume of 298,940. The company has a debt-to-equity ratio of 0.17, a current ratio of 13.42 and a quick ratio of 13.05. The firm has a market cap of $1.71 billion, a price-to-earnings ratio of -47.22 and a beta of 1.27. Inspire Medical Systems has a 52-week low of $35.43 and a 52-week high of $72.31. The stock has a 50 day simple moving average of $60.90 and a 200 day simple moving average of $61.66.

In other news, insider Randy Ban sold 10,000 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $61.62, for a total value of $616,200.00. Also, Director Orbimed Advisors Llc sold 53,387 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $71.63, for a total transaction of $3,824,110.81. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 229,577 shares of company stock worth $15,219,882. 12.10% of the stock is currently owned by insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Man Group plc acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $5,739,000. Partner Investment Management L.P. acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $217,000. Redmile Group LLC acquired a new stake in shares of Inspire Medical Systems in the third quarter worth $239,000. California State Teachers Retirement System increased its position in shares of Inspire Medical Systems by 1.8% in the third quarter. California State Teachers Retirement System now owns 20,887 shares of the company’s stock worth $1,275,000 after acquiring an additional 377 shares in the last quarter. Finally, Stifel Financial Corp grew its holdings in Inspire Medical Systems by 22.4% during the 3rd quarter. Stifel Financial Corp now owns 7,637 shares of the company’s stock valued at $467,000 after purchasing an additional 1,398 shares in the last quarter. 89.74% of the stock is owned by institutional investors.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Recommended Story: How to Invest in Growth Stocks

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.